BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8971307)

  • 1. Ranitidine bismuth citrate therapy.
    Harris A; Misiewicz JJ
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1035. PubMed ID: 8971307
    [No Abstract]   [Full Text] [Related]  

  • 2. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
    Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay].
    Cuena Boy R
    An Med Interna; 2002 Aug; 19(8):439-40; author reply 440. PubMed ID: 12244799
    [No Abstract]   [Full Text] [Related]  

  • 10. Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
    Dixon JS; Pipkin GA; Mills JG; Wood JR
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():47-58. PubMed ID: 9440055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in Helicobacter pylori eradication therapy.
    Pounder RE
    Scand J Gastroenterol Suppl; 1997; 223():43-5. PubMed ID: 9200305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal strategy of treatment of Helicobacter pylori infection: renaissance of antisecretory drugs?
    Nijevitch AA; Farztdinov KM; Sataev VU; Dashkova S; Kazykhanov NS
    Am J Gastroenterol; 2001 Mar; 96(3):921-2. PubMed ID: 11280584
    [No Abstract]   [Full Text] [Related]  

  • 15. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori.
    Meyer JM; Hopkins RJ
    N Engl J Med; 2003 Jan; 348(4):363-5. PubMed ID: 12540657
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
    Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?
    Markova T; Schwartz K
    J Fam Pract; 2002 Jan; 51(1):14. PubMed ID: 11927054
    [No Abstract]   [Full Text] [Related]  

  • 19. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer.
    Bardhan KD; Dekkers CP; Lam SK; Nowak A; Schaffalitzky de Muckadell OB; Schutze K; Tildesley G; Kler L; Forster JK; Lacey LF
    Aliment Pharmacol Ther; 1995 Oct; 9(5):497-506. PubMed ID: 8580269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.